Cuts, ousters and drama at the FDA
9 Articles
9 Articles
FDA Names New Acting Vaccine Leader After Previous Chief’s Departure
After its top vaccine official left the Food and Drug Administration (FDA), the agency announced Tuesday that it has named his replacement. In an April 1 statement on X, the FDA said Scott Steele would be the acting head of the Center for Biologics Evaluation and Research (CBER), which Peter Marks once led. “Dr. Steele is a science, technology, and policy professional at FDA with extensive experience in multiple disciplines, including emerging s…
FDA layoffs, ouster of top leaders dampen biotech investment
A biotech market that initially showed signs of optimism after the election of the second Trump administration is now reeling not only from the widespread tariffs announced Wednesday, but from job cuts and the departure of top leaders at the FDA.
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage